Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Poxvirus recombinant vaccines.

E Paoletti1

  • 1Virogenetics, Rensselaer Technology Park, Troy, New York 12180.

Annals of the New York Academy of Sciences
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Recombinant poxviruses, including vaccinia and fowlpox, show great potential as live vaccines. Engineered poxviruses offer versatile applications in both human and veterinary medicine, with surprising efficacy in non-avian species.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Economic Evaluation of Patiromer in Patients with Concomitant Heart Failure and Chronic Kidney Disease in Italy.

PharmacoEconomics - open·2025
Same author

Pragmatic diagnostic and therapeutic algorithms to optimize new potassium binder use in cardiorenal disease.

Pharmacological research·2022
Same author

Chronic ozone exposure preferentially modifies root rather than foliar metabolism of date palm (Phoenix dactylifera) saplings.

The Science of the total environment·2021
Same author

Exploring new strategies for ozone-risk assessment: A dynamic-threshold case study.

Environmental pollution (Barking, Essex : 1987)·2021
Same author

Ten-Year Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant: A Prospective Cohort Study.

Transplantation proceedings·2020
Same author

Descriptive study of the general practitioners' perception of direct oral anticoagulants and the risk of genital bleeding in women of childbearing age.

Journal de medecine vasculaire·2020
Same journal

Multiomics Profiling During Autoimmune Demyelination Highlights a Complex Regulatory Role for Ataxin-1 in B Cells.

Annals of the New York Academy of Sciences·2026
Same journal

Global Trends in Light Pollution and Their Relationship With Socioeconomic Factors.

Annals of the New York Academy of Sciences·2026
Same journal

Wired for Corruption: Inter-Brain Synchrony Encodes Bribery-Related Value Information and Predicts Bribery Agreement.

Annals of the New York Academy of Sciences·2026
Same journal

LM-YOLO: A Lightweight Multi-Scale Enhanced Model for Forest Smoke Detection Using Unmanned Aerial Vehicles.

Annals of the New York Academy of Sciences·2026
Same journal

Polyrhythm Perception and Production: A Scoping Review.

Annals of the New York Academy of Sciences·2026
Same journal

DARTS-CNN-BiLSTM: Intelligent Fault Diagnosis for Computer Numerical Control Machine Tool Feed System.

Annals of the New York Academy of Sciences·2026
See all related articles

Area of Science:

  • Virology
  • Vaccinology
  • Molecular Biology

Background:

  • Poxviruses, specifically Orthopoxvirus (vaccinia) and Avipoxvirus (fowlpox), are classified into six genera based on cross-neutralization and host-range.
  • Genetic engineering of these viruses allows for the expression of heterologous genes, creating recombinant viruses.

Purpose of the Study:

  • To assess the potential of genetically engineered poxviruses as live recombinant vaccine candidates.
  • To highlight the diverse applications of vaccinia and avipoxvirus vectors in human, veterinary, and avian medicine.

Main Methods:

  • Genetic engineering of vaccinia and fowlpox viruses to express foreign genes.
  • Evaluation of recombinant viruses as live vaccine candidates.
  • Assessment of host range and efficacy in various species.

Related Experiment Videos

Main Results:

  • Vaccinia virus recombinants demonstrate broad host range, suitable for human and veterinary applications.
  • Avipoxvirus recombinants, typically restricted to avian species, show promise for poultry diseases.
  • Intriguingly, recombinant avipoxviruses also exhibit efficacy in non-avian species.
  • Recombinant live vaccines can be amplified in tissue culture but are non-proliferative in vivo.

Conclusions:

  • Recombinant poxviruses represent a promising platform for developing novel live vaccines.
  • The distinct host ranges of vaccinia and avipoxvirus vectors offer tailored applications.
  • The unexpected efficacy of avipoxviruses in non-avian species warrants further investigation.